secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2025-01-16T23:59:59+00:00
Accession:  0001213900-25-004200
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell settles insurance claim for $426,587; total recovery $676,587 from contamination events
--------------------------------------------------------------------------------

- Settlement of $426,587 received for production contamination losses from late 2022 through April 2024.
- This amount is in addition to the $250,000 previously recognized in Q3 2023, bringing total claim recovery to $676,587.
- The insurance claim was long outstanding; settlement resolves coverage for previously disclosed contamination events.
- Company plans to report Q4 and full-year 2024 results on conference call February 26, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000121390025004200/0001213900-25-004200-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000121390025004200/ea0227944-8k_immucell.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-004200

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer